Skip to main content
Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · IEX Real-Time Price · USD
21.74
+0.52 (2.45%)
At close: May 1, 2024, 4:00 PM
22.44
+0.70 (3.22%)
After-hours: May 1, 2024, 6:27 PM EDT

Beam Therapeutics Revenue

In the year 2023, Beam Therapeutics had annual revenue of $377.71M with 520.01% growth. Revenue in the quarter ending December 31, 2023 was $316.19M with 1,478.04% year-over-year growth.

Revenue (ttm)
$377.71M
Revenue Growth
+520.01%
P/S Ratio
4.70
Revenue / Employee
$744,988
Employees
507
Market Cap
1.78B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023377.71M316.79M520.01%
Dec 31, 202260.92M9.08M17.51%
Dec 31, 202151.84M51.82M215,916.67%
Dec 31, 202024.00K6.00K33.33%
Dec 31, 201918.00K--
Dec 31, 20180--
Dec 31, 20170--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Astrana Health 1.39B
Myriad Genetics 753.20M
Supernus Pharmaceuticals 607.52M
Harmony Biosciences Holdings 582.02M
Alphatec Holdings 482.26M
Catalyst Pharmaceuticals 398.20M
Schrödinger 216.67M
Agios Pharmaceuticals 26.82M
Revenue Rankings

BEAM News

More News